Maculopathy associated with mefloquine (Lariam) therapy for malaria prophylaxis.
We report maculopathy occurring in a patient after 18 months of weekly mefloquine for malaria prophylaxis. Macular retinal pigment epithelium changes bilaterally were visually insignificant, with the patient demonstrating 20/20 corrected visual acuity bilaterally. Retinal change as an adverse effect of mefloquine has not previously been reported.